Hsu-Shan Huang

According to our database, Hsu-Shan Huang authored at least 2 papers between 2022 and 2025.

Collaborative distances:

• Dijkstra number of five.
• Erdős number of five.

2025

Computer-aided drug discovery of a dual-target inhibitor for ovarian cancer: therapeutic intervention targeting CDK1/TTK signaling pathway and structural insights in the NCI-60.

Sung-Ling Tang, Maryam Rachmawati Sumitra, Yu-Cheng Kuo, Han-Lin Hsu, Muhamad Ansar, Sheng-Liang Huang, Shih-Yu Lee, Hong-Jaan Wang, Bashir Lawal, Alexander T. H. Wu, Lung-Ching Chen, Hsu-Shan Huang

Comput. Biol. Medicine, 2025

2022

Identification of a novel immune-inflammatory signature of COVID-19 infections, and evaluation of pharmacokinetics and therapeutic potential of RXn-02, a novel small-molecule derivative of quinolone.

Bashir Lawal, Yu-Cheng Kuo, Maryam Rachmawati Sumitra, Alexander T. H. Wu, Hsu-Shan Huang

Comput. Biol. Medicine, 2022